Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 659 of 5804
-
Quick HIV test at birth could get infants on better meds faster
Disease control OngoingThis study is being conducted to explore the feasibility of implementing targeted birth HIV testing of high-risk neonates using facility-based point-of-care (POC) HIV diagnostics, and to improve the ability to implement the best standard-of-care treatment possible. Infants found …
Phase: PHASE4 • Sponsor: Harvard School of Public Health (HSPH) • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Ketamine shows promise for bipolar depression in new trial
Symptom relief CompletedGrowing evidence has supported rapid and robust antidepressant effects with subanesthetic doses of intravenous (IV) ketamine for treatment resistant depression (TRD). However, no completed or ongoing randomized control trials (RCTs) have evaluated the effects of repeated doses of…
Phase: PHASE2 • Sponsor: Joshua Rosenblat • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
New migraine drug shows promise for those caught in a Headache-Medication cycle
Disease control CompletedMedication overuse headache (MOH) is a type of headache caused by excessive use of acute headache or migraine medications (medications used to treat a headache or migraine once it begins). Treatment of MOH usually involves reducing the dose of or discontinuing acute medications. …
Phase: PHASE4 • Sponsor: H. Lundbeck A/S • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New drug cocktail shows promise for tough bile duct cancer
Disease control OngoingTo evaluate the following items in patients with advanced cholangiocarcinoma receiving lenvatinib plus paclitaxel treatment, Primary endpoint: Overall response rate (ORR) by RECIST 1.1 Secondary endpoints Progression-free survival (PFS) Time to progression Overall survival Diseas…
Phase: PHASE2 • Sponsor: National Health Research Institutes, Taiwan • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New hope for tough brain tumors: experimental drug targets recurrent meningioma
Disease control Recruiting nowThis multi-site, Phase 2 clinical trial is an open-label study to identify the safety, pharmacokinetics, and efficacy of a repeated dose regimen of NEO100 (perillyl alcohol) for the treatment of patients with residual high-grade meningioma following resection surgery, radiographi…
Phase: PHASE2 • Sponsor: Neonc Technologies, Inc. • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New combo therapy aims to keep High-Risk myeloma in check
Disease control Recruiting nowIxazomib combined with low-dose lenalidomide(10mg) vs Ixazomib alone as maintenance regimen in patients with high-risk multiple myeloma after induction and consolidation of VRD-based regimen.
Phase: PHASE4 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Could a transplant drug help patients with rare muscle disease?
Disease control OngoingThe hypothesis is that Sirolimus, (Rapamycin (R)) which is currently used in organ transplantation and works by blocking the activity of T effector cells but preserving T regulatory cells, as well as by inducing autophagy (protein degradation), will be effective in IBM to slow or…
Phase: PHASE3 • Sponsor: University of Kansas Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Diabetes drug metformin tested to boost brain recovery in young cancer survivors
Symptom relief Recruiting nowThe efficacy of treatment with metformin for promoting cognitive recovery and brain growth in children/adolescents treated for a brain tumour will be investigated in a multi-site Phase III randomized double-blind placebo-controlled parallel arm superiority trial. Specifically, in…
Phase: PHASE3 • Sponsor: Donald Mabbott • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
Can faster 911 and CPR training double cardiac arrest survival?
Knowledge-focused OngoingRACE-CARS is a real-world cluster-randomized trial designed to evaluate a multifaceted community and health systems intervention aimed to improve outcomes of out-of-hospital cardiac arrest. RACE-CARS will enroll 50 counties in North Carolina that are estimated to have a total of …
Phase: NA • Sponsor: Duke University • Aim: Knowledge-focused
Last updated Jul 18, 2026 00:00 UTC
-
Could a broccoli sprout compound protect aging hearts?
Disease control TerminatedOur local IRB approved clinical studies seeking proof of principle for the hypothesis that SFN can be safely administered to humans at doses sufficient to protect age-associated cardiac dysfunctions. Beneficial effects of SFN-therapy will be assessed by Pre- and post-intervention…
Phase: PHASE1, PHASE2 • Sponsor: Texas Tech University Health Sciences Center • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New asthma drug shows promise in reducing severe attacks
Disease control CompletedThis was a parallel, Phase 2, global, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, four-arms study for treatment. The purpose of this study was to assess the efficacy, safety, and tolerability of add-on therapy with amlitelimab in adult participants w…
Phase: PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Can a drug cocktail revive immunotherapy for breast cancer?
Disease control Recruiting nowThis is a Phase II, open-label, seven-arm parallel study evaluating the efficacy and safety of combined treatment (sodium cromoglicate, choline, efavirenz, SHR 1811, SHR 2102, mecapegfilgrastim, theophylline) with immune checkpoint inhibitor or immune checkpoint inhibitor rechall…
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
ICD or not? landmark trial tests defibrillator necessity in seniors with heart failure.
Disease control Recruiting nowThe primary objective of DILEMMA study is to assess whether the "heart failure optimal therapy alone (HFOT)" strategy is non inferior to the "HFOT+ICD" strategy in terms of overall survival 48 months after randomization, in patients ≥ 70 years with an ICD indication for primary p…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Algorithm could spot hidden dementia in routine doctor visits
Diagnosis CompletedThe eRADAR Brain Health Study seeks to refine and test a novel, low-cost strategy for increasing dementia detection within primary care.
Phase: NA • Sponsor: Kaiser Permanente • Aim: Diagnosis
Last updated Jul 08, 2026 00:00 UTC
-
New psoriasis drug could rival stelara in major trial
Disease control CompletedThis is a randomized, double-blind, active-controlled, parallel-group, multicenter study designed to compare the efficacy, safety, immunogenicity, and PK(Pharmacokinetic) of Bmab 1200 with Stelara in adult patients with moderate to severe chronic plaque psoriasis.
Phase: PHASE3 • Sponsor: Biocon Biologics UK Ltd • Aim: Disease control
Last updated Jun 26, 2026 16:50 UTC
-
New microscope could help brain surgeons see tumors in real time
Diagnosis Recruiting nowThe primary objective of this study is to evaluate the diagnostic performance of the CONVIVO confocal endomicroscope in discriminating between normal and abnormal tissue in vivo during brain tumor surgery. The interpretation of intraoperative images obtained in situ will be teste…
Phase: NA • Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 09:02 UTC
-
Could a cancer drug slow MS progression? new trial halted midway
Disease control TerminatedTo evaluate the efficacy and safety of oral masitinib versus placebo in the treatment of patients with primary progressive or secondary progressive multiple sclerosis without relapse.
Phase: PHASE3 • Sponsor: AB Science • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New combo attack on rare cancer: immunotherapy joins chemo
Disease control TerminatedThis phase II/III trial compares the effect of immunotherapy with atezolizumab in combination with standard chemotherapy with a platinum drug (cisplatin or carboplatin) and etoposide versus standard therapy alone for the treatment of poorly differentiated extrapulmonary (originat…
Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Oxygen dilemma: which level saves preterm brains?
Disease control Recruiting nowPreterm birth, or birth before 37 weeks' gestation, is increasingly common, occurring in 8 percent of pregnancies in Canada. Preterm birth is associated with many health complications, particularly when the birth happens before 29 weeks' gestation. At this gestational age, the lu…
Phase: NA • Sponsor: University of Alberta • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Immuno-chemo combo takes on hard-to-treat lymphoma
Disease control OngoingThis is an open-label, multicentre, randomised phase II trial in relapsed or refractory diffuse large B-cell lymphoma.
Phase: PHASE2 • Sponsor: University of Southampton • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC